During the past decade, Alan L Robin, M.D. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Alan L Robin, M.D." are "Ocular Hypertension" (3 trials), "Open Angle Glaucoma" (2 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "Alan L Robin, M.D." in a lesser frequency.

Most popular intervention types in "Alan L Robin, M.D." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "AR-12286 Ophthalmic Solution 0.5%" (2 trials), "AR-13324 Ophthalmic Solution 0.01%" (1 trials), "AR-13324 Ophthalmic Solution 0.02%" (1 trials), "Latanoprost 0.005%" (1 trials) and "Latanoprost ophthalmic solution 0.005%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alan L Robin, M.D." are 3 trials for "All" genders.

Currently, there are NaN active trials in "Alan L Robin, M.D.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Alan L Robin, M.D., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alan L Robin, M.D., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".